68 / 74 · 0:51 · Original AXON film
Ibutamoren / MK-677
The burned-in captions and transcript carry the scientific claims and their limitations. The visuals are conceptual illustrations, not validated molecular models or experimental images. The video has no voice or audio. The full explanation is visible on screen; optional accessible captions are available in the player.
Read every result in its study context. A cell experiment, animal model, exploratory analysis and controlled human trial answer different questions.
Prepared 05 November 2026. Regulatory status is jurisdiction- and date-specific. No claim of specialist review or exhaustive evidence coverage.
Transcript
MK-677 | Non-peptide secretagogue
Ibutamoren, also called MK-677, is a non-peptide compound that mimics ghrelin signaling. Research has examined its effects on growth hormone and body composition. [1]
HUMAN TRIAL | Mass and function differ
A randomized trial in healthy older adults found increased growth hormone and fat-free mass. However, increased mass did not translate into improved strength or function. [1]
Metabolic and tolerability findings matter
The study also reported increased fasting glucose and reduced insulin sensitivity. Appetite, swelling and muscle discomfort were among the observed issues that complicate the picture. [1]
Patient benefit includes function and safety
Body-composition measurements are useful, but they are only part of the assessment. Durable functional benefits and harms need to be evaluated together. [1]
Sources and context
These linked sources support the evidence distinctions in this short overview. This is not a systematic review, endorsement or treatment recommendation.
- Nass et al. (2008): Effects of an oral ghrelin mimetic on body composition and clinical outcomes in healthy older adults →GH and fat-free mass findings; no demonstrated strength/function improvement; glucose, insulin sensitivity and tolerability findings.
